Routine I position absolutely enhances the volume of complexity for just about any study review. As an example, all researchers—whether preclinical or scientific—have to receive Schedule I study registrations. 21 CFR portion 1301.18. Against this, researchers who may have DEA Practitioner registrations in Schedules II–V (which most physicians